1.48
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Zynex Inc stock is traded at $1.48, with a volume of 58,465.
It is up +2.07% in the last 24 hours and up +1.37% over the past month.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
See More
Previous Close:
$1.45
Open:
$1.45
24h Volume:
58,465
Relative Volume:
0.25
Market Cap:
$44.84M
Revenue:
$193.67M
Net Income/Loss:
$4.82M
P/E Ratio:
10.55
EPS:
0.1403
Net Cash Flow:
$15.53M
1W Performance:
+2.78%
1M Performance:
+1.37%
6M Performance:
-29.86%
1Y Performance:
-80.88%
Zynex Inc Stock (ZYXI) Company Profile
Name
Zynex Inc
Sector
Industry
Phone
(800)-495-6670
Address
9655 MAROON CIRCLE, ENGLEWOOD, CO
Compare ZYXI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
9.30 | 0 | 0 | 0 | 0 | 0.00 | |
![]()
MOBBW
Mobilicom Limited Warrants
|
4.27 | 5.37B | 0 | 0 | 0 | 0.00 |
![]()
GOODO
Gladstone Commercial Corporation
|
20.13 | 372.90M | 0 | 0 | 0 | 0.00 |
![]()
SHMD
Schmid Group N V
|
2.50 | 116.70M | 0 | 0 | 0 | 0.00 |
![]()
PSNYW
Polestar Automotive Holding Uk
|
0.2651 | 546.35M | 2.07B | -1.42B | -1.37B | -0.6765 |
![]()
DAVEW
Dave Inc
|
1.0499 | 0 | 0 | 0 | 0 | 0.00 |
Zynex Inc Stock (ZYXI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-01-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
Aug-01-25 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
Mar-12-25 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Mar-12-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Oct-16-23 | Initiated | RBC Capital Mkts | Outperform |
Jan-06-23 | Upgrade | Piper Sandler | Neutral → Overweight |
Feb-28-22 | Reiterated | B. Riley Securities | Buy |
Jul-16-21 | Upgrade | B. Riley Securities | Neutral → Buy |
Mar-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
Feb-26-21 | Downgrade | B. Riley Securities | Buy → Neutral |
Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
Jan-28-21 | Downgrade | Northland Capital | Outperform → Market Perform |
Sep-14-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
Sep-09-20 | Upgrade | Northland Capital | Market Perform → Outperform |
Jul-29-20 | Upgrade | B. Riley FBR | Neutral → Buy |
Jul-20-20 | Initiated | Piper Sandler | Overweight |
Jul-13-20 | Downgrade | B. Riley FBR | Buy → Neutral |
Jul-10-20 | Reiterated | H.C. Wainwright | Neutral |
Jun-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
May-19-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
Apr-01-20 | Initiated | Northland Capital | Outperform |
Sep-23-19 | Initiated | H.C. Wainwright | Buy |
View All
Zynex Inc Stock (ZYXI) Latest News
Colorado medtech company laying off more of its employees - The Business Journals
Zynex Seeks Partner for NiCO CO-Oximeter Commercialization - TipRanks
Zynex announces workforce reduction and $31 million asset impairment at subsidiary - Investing.com
Zynex terminated positions of a majority of ZMS employees - MarketScreener
Is this a good reentry point in Zynex Inc.Market Performance Recap & Fast Exit and Entry Strategy Plans - newser.com
Using flow based indicators on Zynex Inc.July 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zynex, Inc. (ZYXI) And Encourages Investors to Connect - ACCESS Newswire
Zynex Inc. stock chart pattern explainedQuarterly Portfolio Summary & Long-Term Safe Investment Plans - newser.com
What MACD and RSI say about Zynex Inc.2025 Growth vs Value & Long-Term Growth Stock Strategies - newser.com
Zynex Investors Seek To Merge, Stay Insider Trading Suits - Law360
Visual trend scoring systems applied to Zynex Inc.July 2025 Drop Watch & Accurate Buy Signal Alerts - newser.com
Is Zynex Inc. stock attractive for long term wealth buildingEarnings Beat & Stock Portfolio Risk Control - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zynex, Inc. (ZYXI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-09-30 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zynex, Inc. (ZYXI) and Encourages Investors to Learn More About the Investigation | NDAQ:ZYXI | Press Release - Stockhouse
Zynex (NASDAQ:ZYXI) versus Insulet (NASDAQ:PODD) Head to Head Review - Defense World
What drives Zynex Inc stock priceStock Watchlist Updates & Low Risk Portfolio Growth - earlytimes.in
Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
What analysts say about Zynex Inc stockMarket Liquidity Analysis & Free Webinars On Market Trends - earlytimes.in
2025-09-28 | Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ZYXI | Press Release - Stockhouse
ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Zynex Appoints Anna Lucsok as Chief Commercial Officer - The Globe and Mail
Zynex shifts Anna Lucsok from COO to chief commercial officer By Investing.com - Investing.com Australia
Zynex shifts Anna Lucsok from COO to chief commercial officer - Investing.com
What recovery options are there for Zynex Inc.Market Trend Review & Smart Investment Allocation Insights - newser.com
Full technical analysis of Zynex Inc. stock2025 Support & Resistance & Capital Protection Trading Alerts - newser.com
Zynex, Inc.(NasdaqGS: ZYXI) dropped from S&P Global BMI Index - MarketScreener
Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2025-09-21 | Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:ZYXI | Press Release - Stockhouse
Heatmap analysis for Zynex Inc. and competitorsTrade Signal Summary & AI Forecasted Entry/Exit Points - newser.com
Can swing trading help recover from Zynex Inc. lossesShort Setup & Long Hold Capital Preservation Plans - newser.com
Growth Value: Is Zynex Inc in a consolidation phaseGlobal Markets & Daily Oversold Stock Bounce Ideas - خودرو بانک
Zynex Inc. stock trend outlook and recovery pathWeekly Trade Report & Fast Gaining Stock Reports - newser.com
Custom strategy builders for tracking Zynex Inc.Weekly Risk Report & Advanced Swing Trade Entry Plans - newser.com
Real time pattern detection on Zynex Inc. stock2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
Zynex Inc Stock (ZYXI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zynex Inc Stock (ZYXI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
MOORHEAD DANIEL J | CHIEF FINANCIAL OFFICER |
Feb 03 '25 |
Sale |
7.68 |
10,000 |
76,800 |
19,738 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):